Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02890758
Title Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors David Wald
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.